1. Home
  2. MCHX vs CLSD Comparison

MCHX vs CLSD Comparison

Compare MCHX & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCHX
  • CLSD
  • Stock Information
  • Founded
  • MCHX 2003
  • CLSD 2011
  • Country
  • MCHX United States
  • CLSD United States
  • Employees
  • MCHX N/A
  • CLSD N/A
  • Industry
  • MCHX Business Services
  • CLSD Biotechnology: Pharmaceutical Preparations
  • Sector
  • MCHX Consumer Discretionary
  • CLSD Health Care
  • Exchange
  • MCHX Nasdaq
  • CLSD Nasdaq
  • Market Cap
  • MCHX 84.3M
  • CLSD 68.6M
  • IPO Year
  • MCHX 2004
  • CLSD 2016
  • Fundamental
  • Price
  • MCHX $1.45
  • CLSD $0.90
  • Analyst Decision
  • MCHX
  • CLSD Strong Buy
  • Analyst Count
  • MCHX 0
  • CLSD 5
  • Target Price
  • MCHX N/A
  • CLSD $5.20
  • AVG Volume (30 Days)
  • MCHX 18.2K
  • CLSD 103.8K
  • Earning Date
  • MCHX 05-13-2025
  • CLSD 05-14-2025
  • Dividend Yield
  • MCHX N/A
  • CLSD N/A
  • EPS Growth
  • MCHX N/A
  • CLSD N/A
  • EPS
  • MCHX N/A
  • CLSD N/A
  • Revenue
  • MCHX $48,122,000.00
  • CLSD $1,664,000.00
  • Revenue This Year
  • MCHX $6.83
  • CLSD N/A
  • Revenue Next Year
  • MCHX N/A
  • CLSD $675.15
  • P/E Ratio
  • MCHX N/A
  • CLSD N/A
  • Revenue Growth
  • MCHX N/A
  • CLSD N/A
  • 52 Week Low
  • MCHX $1.23
  • CLSD $0.70
  • 52 Week High
  • MCHX $2.40
  • CLSD $1.65
  • Technical
  • Relative Strength Index (RSI)
  • MCHX 47.74
  • CLSD 56.82
  • Support Level
  • MCHX $1.36
  • CLSD $0.81
  • Resistance Level
  • MCHX $1.50
  • CLSD $0.92
  • Average True Range (ATR)
  • MCHX 0.11
  • CLSD 0.06
  • MACD
  • MCHX 0.01
  • CLSD 0.01
  • Stochastic Oscillator
  • MCHX 59.38
  • CLSD 83.17

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

Share on Social Networks: